According to a research report published this morning, Citi has upgraded The Clorox Company CLX from Neutral to Buy, and raised PT from $72 to $78.
Citi said in the report, "Over the last year, it seems to us as if CLX has become more confident in its business—and today's analyst meeting revealed to us a mgmt team that seemed (i) happy with their current portfolio, (ii) satisfied with their solid execution over the last several quarters and (iii) genuinely excited about their prospects to deliver even stronger shareholder returns over the next several years."
Clorox closed yesterday at $68.98.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in